Abstract
Objectives
To visualize and quantitatively assess regional lung function of survivors of COVID-19 who were hospitalized using pulmonary free-breathing 1H MRI.
Methods
A total of 12 healthy volunteers and 27 COVID-19 survivors (62.4 ± 8.1 days between infection and image acquisition) were recruited in this prospective study and performed chest 1H MRI acquisitions with free tidal breathing. Then, conventional Fourier decomposition ventilation (FD-V) and global fractional ventilation (FVGlobal) were analyzed. Besides, a modified PREFUL (mPREFUL) method was developed to adapt to COVID-19 survivors and generate dynamic ventilation maps and parameters. All the ventilation maps and parameters were analyzed using Student’s t-test. Pearson’s correlation and a Bland-Altman plot between FVGlobal and mPREFUL were analyzed.
Results
There was no significant difference between COVID-19 and healthy groups regarding a static FD-V map (0.47 ± 0.12 vs 0.42 ± 0.08; p = .233). However, mPREFUL demonstrated lots of regional high ventilation areas (high ventilation percentage (HVP): 23.7% ± 10.6%) existed in survivors. This regional heterogeneity (i.e., HVP) in survivors was significantly higher than in healthy volunteers (p = .003). The survivors breathed deeper (flow-volume loop: 5375 ± 3978 vs 1688 ± 789; p = .005), and breathed more air in respiratory cycle (total amount: 62.6 ± 19.3 vs 37.3 ± 9.9; p < .001). Besides, mPREFUL showed both good Pearson’s correlation (r = 0.74; p < .001) and Bland-Altman consistency (mean bias = −0.01) with FVGlobal.
Conclusions
Dynamic ventilation imaging using pulmonary free-breathing 1H MRI found regional abnormity of dynamic ventilation function in COVID-19 survivors.
Key Points
• Pulmonary free-breathing1H MRI was used to visualize and quantitatively assess regional lung ventilation function of COVID-19 survivors.
• Dynamic ventilation maps generated from 1H MRI were more sensitive to distinguish the COVID-19 and healthy groups (total air amount: 62.6 ± 19.3 vs 37.3 ± 9.9; p < .001), compared with static ventilation maps (FD-V value: 0.47 ± 0.12 vs 0.42 ± 0.08; p = .233).
• COVID-19 survivors had larger regional heterogeneity (high ventilation percentage: 23.7% ± 10.6% vs 13.1% ± 7.9%; p = .003), and breathed deeper (flow-volume loop: 5375 ± 3978 vs 1688 ± 789; p = .005) than healthy volunteers.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
As of December 2021, more than 260 million people worldwide have been infected with coronavirus disease 2019 (COVID-19) [1, 2]. Recent studies indicated long-term lung function damage might exist among discharged COVID-19 survivors [3]. Previous studies on other coronavirus infections also showed persistent impairment on lung function would last for years [4]. Attention has been paid on assessment of COVID-19 survivors using pulmonary function tests (PFTs) [5,6,7,8,9]. However, PFTs have limited sensitivity to regional abnormalities, while regional lung function imaging could directly visualize function at regional and whole level [10].
Single-photon emission computed tomography (SPECT) is currently the gold standard of regional lung function imaging [11, 12]. CT ventilation imaging (CTVI) [13] and its variant N-Phase ventilation method [14] could also assess regional ventilation, and recently, CTVI was used to predict lung lesions in the early stage of COVID-19 disease [15]. Nevertheless, SPECT and CTVI are limited by radiation. Hyperpolarized gas magnetic resonance imaging (MRI) has also been used for functional imaging of lung [16,17,18], and our group detected damaged lung gas-exchange function with hyperpolarized 129Xe MRI in COVID-19 survivors [19]. Hyperpolarized 129Xe MRI requires significant equipment and technical expertise and is thus currently not suitable for usage outside of expert centers.
Proton (1H) MRI is one of the most widely used medical imaging modality [20, 21]. With development of fast acquisition and image processing, 1H MRI could be used to assess regional lung function based on image registration or Fourier decomposition (FD) [22, 23]. Previous studies have shown 1H MRI is a promising method for imaging lung ventilation function without radioactivity [24,25,26,27,28,29,30,31,32]. Howbeit, most methods do not visualize dynamic process of ventilation and might conceal some abnormal regions [33, 34]. Recently a phase-resolved functional lung (PREFUL) MRI method was proposed to quantify regional dynamic ventilation using pulmonary free-breathing 1H MRI acquisition [35,36,37,38,39]. PREFUL MRI has been demonstrated to be more sensitive for detecting regional abnormity compared with static ventilation measurements.
Base on the above, we intend to visualize and quantitatively assess regional ventilation function of COVID-19 survivors using pulmonary free-breathing 1H MRI. In this work, a modified PREFUL method (mPREFUL) is developed to adapt to COVID-19 survivors and generate dynamic ventilation maps and parameters. Besides, conventional FD ventilation (FD-V) [23] and global fractional ventilation (FVGlobal) [40] are also analyzed. We anticipate regional lung ventilation imaging using free-breathing 1H MRI could help interpret the causes of lung dysfunction in COVID-19 survivors.
Materials and methods
Study subjects
A total of 12 healthy volunteers and 27 COVID-19 survivors were recruited in this prospective study. The local institutional review board approved the experiments and informed written consent was obtained from each subject. The survivors were discharged from Tongji Hospital, Wuhan, China, from February 4 to March 5, 2020. The inclusion criteria of survivors and healthy volunteers were as follows: (1) the survivors and healthy volunteers had no previous history of pulmonary disease or smoking; (2) the discharge time of survivors was about 1 month; (3) the age of healthy volunteers was close to the survivors as possible. One healthy volunteer and six COVID-19 survivors were excluded because of image quality (low SNR, motion artifacts, etc.). According to the guidelines of diagnosis of COVID-19 pneumonia [3, 41], the rest of the survivors were divided into mild and severe groups based on clinical symptoms during hospitalization (e.g., whether respiratory rate > 30 breaths/min or oxygen saturations < 93% at rest state).
Thus, a total of 11 healthy volunteers (mean age ± standard deviation (SD), 34 ± 6 years, and 5 females) and 21 COVID-19 survivors (39 ± 9 years, 10 females, and divided into 13 mild and 8 severe survivors) were evaluated in this study. The images were acquired 62.4 ± 8.1 days later after the COVID infection. Among these survivors, 5 (23.8%) had long COVID-19 symptoms (3 had dyspnea, 1 had chest pain, and 1 had palpitations). The remaining survivors had no obviously long COVID-19 symptoms (e.g., fatigue, cough). Demography characteristics of subjects are summarized in Table 1.
Image acquisitions
Pulmonary free-breathing 1H MRI images were acquired from all subjects using a 3-T scanner (uMR 780, United Imaging Healthcare) in head-first supine position. One coronal slice at the middle of lungs was acquired using a chest coil. The acquisitions were performed during free tidal breathing using a spoiled gradient echo sequence over a period of 85 s at a temporal resolution of 0.441 s (total 192 time-series 1H MRI images for each subject). The sequence settings were field of view 50 × 50 cm2, matrix size 256 × 256, slice thickness 15 mm, echo time 1.04 ms, repetition time 3 ms, flip angle 5°, and bandwidth 384 kHz (1500 Hz/pixel × 256 pixel).
Dynamic ventilation imaging
The acquired time-series 1H MRI images were pre-processed (e.g., first three images omitted, de-noising, lung segmentation) and spatially co-registered [23]. Then, dynamic ventilation maps were generated by using mPREFUL. The general framework of mPREFUL included three major steps: (1) time-series signal construction, (2) full respiratory cycle (FRC) reconstruction, and (3) dynamic ventilation maps generation, as shown in Fig. 1. Compared with original PREFUL [35], an automatic method was used to construct time-series signal in mPREFUL, and thus the dynamic ventilation maps could be automatically generated. Besides, the actual respiratory cycle time in FRC of each subject was calculated in mPREFUL. Correspondingly, the dynamic ventilation imaging of subjects was assessed based on their real respiratory time. The detailed description of mPREFUL is provided in the Supplementary Material.
The framework of mPREFUL by using free-breathing 1H MRI, which contained three steps. Step 1 served to construct time-series signal according to the mean values of lung proton density. Step 2 served to sort the time-series signal in exp-phase and insp-phase of the full respiratory cycle (FRC), and then calculate the respiratory phase and respiratory time of each image according to the cosine model. Step 3 served to calculate the dynamic 1H-density difference and relative difference maps between each time point image and the end-exp image in the FRC. Note that the proton density was expressed in arbitrary units (a.u.)
Dynamic ventilation parameters
In mPREFUL, the dynamic 1H-density difference maps [22] and relative difference maps [26] between each time point (tx) 1H MRI image and end-exp 1H MRI image in FRC were used to represent the dynamic ventilation maps (denoted as V(tx) maps) and dynamic fractional ventilation maps (denoted as FV(tx) maps). The mean value of a time point V(tx) map/FV(tx) map was calculated to reflect the air volume/relative air volume that was breathed in that time point. Then, these time-varying scattered points were fitted into a continuous curve, denoted as V(tx) curve or FV(tx) curve. The V(tx) curve and FV(tx) curve directly reflected dynamic change of air amount that was breathed during respiratory cycle. The slopes of V(tx) curve/FV(tx) curve reflected the air flow rate (i.e., the air amount that was breathed per unit time). Specially, the end-insp V(tx) map and FV(tx) map were referred as V100% map and FV100% map, and the mean value of V100%/FV100% map reflected the total air volume/relative air volume that was breathed in whole respiratory cycle. The V(tx) curve and its slopes could be plotted as a closed air flow-volume loop (as displayed in Figure 3), which was used to reflect the breathing state during free tidal breathing [42]. In addition, the regional heterogeneity marker of dynamic ventilation maps was generated from the K-means cluster which was commonly used in the post-processing of ventilation imaging [43].
Validation of mPREFUL
The end-exp and end-insp lung volumes of the free-breathing 1H MRI images were manually extracted and segmented by two radiologists (with more than 10 years of experience in pulmonary imaging diagnosis) [40]. The relative change of end-exp and end-insp lung volumes was calculated and denoted as FVGlobal [40]. The FVGlobal value reflected the relative air volume that was breathed in whole respiratory cycle and could be used to verify the ventilation maps generated from mPREFUL [22, 28, 40].
Statistical analysis
The FD-V maps [23] of the subjects were used as static ventilation maps [36]. To correct out-of-phase ventilation, the N-Phase ventilation method [14] was used to obtain the adjusted dynamic ventilation maps. All the ventilation maps and parameters of different groups were analyzed using unpaired 2-tailed Student’s t-test. Pearson’s correlation and a Bland-Altman plot between mPREFUL and FVGlobal results were analyzed. All the statistical analyses were performed on SPSS statistics software (version 22.0, IBM Inc.). Significance was determined by using a difference with p < 0.05.
Results
Dynamic ventilation maps
Figure 2 shows the dynamic 1H MRI images (at end-exp, middle, and end-insp time points) and corresponding dynamic ventilation maps (at middle and end-insp, i.e., V50% map and V100% map) of a healthy volunteer (male, 31 years old), a mild COVID-19 survivor (female, 47 years old), and a severe COVID-19 survivor (male, 53 years old). The green and red lines denoted the location of diaphragm at end-exp and end-insp. It could be seen that the ranges of diaphragm motion in survivors were relatively deeper than in healthy volunteer. Meanwhile, the signal intensities in V50% map and V100% map of healthy volunteer were homogeneous, while lots of hyperintense signal areas (i.e., high ventilation areas, indicated by red color in ventilation maps) existed in both V50% map and V100% map of survivors. Besides, the changes in regional features between V50% map and V100% map in survivors were also much larger than in healthy volunteer. In details, the proportion of the lung pixels with ventilation values higher than 50% of the maximal ventilation value was used to quantify these changes. The changes of this proportion between V50% map and V100% map in healthy and COVID-19 groups were 1.8% ± 0.8% and 3.7% ± 1.6% (p = 0.001), respectively. Furthermore, the comparison between dynamic ventilation maps and static FD-V maps is shown in Fig. S1 of the Supplementary Material, and the adjusted V100% maps by N-Phase ventilation method are shown in Fig. S2 of the Supplementary Material.
The dynamic 1H MRI images at the end-exp, middle, and end-insp time points, and corresponding dynamic ventilation maps (V(tx) maps) at the middle time point (V50% map) and end-insp time point (V100% map) of a healthy volunteer (male, 31 years old), a mild COVID-19 survivor (female, 47 years old), and a severe COVID-19 survivor (male, 53 years old). The distance between green line and red line in dynamic 1H MRI images indicated the range of diaphragm motion in the respiratory cycle. The hyperintense signal areas (red color areas) of the V50% map and V100% map indicated high ventilation areas
Dynamic ventilation parameters
Figure 3 shows the V(tx) curves, flow-volume loops, and FV(tx) curves of a healthy volunteer (male, 31 years old), a mild COVID-19 survivor (female, 47 years old), and a severe COVID-19 survivor (male, 38 years old). The V(tx) curve in healthy volunteer was relatively flatter than that in survivors. Correspondingly, the slope of the V(tx) curve in survivors was larger, indicating survivors breathed more air per unit time. The peak value of V(tx) curve (i.e., the mean value of V100% map) in survivors was larger, indicating survivors breathed more air in respiratory cycle. The flow-volume loops in survivors were larger, reflecting survivors had a deep breathing state during respiratory cycle. The slope and peak value (i.e., the mean value of FV100% map) of FV(tx) curves in survivors were also larger than those in healthy volunteer, also indicating survivors breathed more air per unit time and breathed more air in respiratory cycle.
The V(tx) curves, flow-volume loops, and FV(tx) curves of a healthy volunteer (male, 31 years old), a mild COVID-19 survivor (female, 47 years old), and a severe COVID-19 survivor (male, 38 years old). In V(tx) curves, the blue points represented the mean values of V(tx) maps at each time point, which were then fitted into continuous curves (black solid curves). In flow-volume loops, the blue points represented the slopes of V(tx) curves at each time point. In FV(tx) curves, the blue points represented the mean values of FV(tx) maps at each time point
Regional dynamic ventilation
Figure 4 shows the regional heterogeneity analysis of the dynamic ventilation maps (V100% maps) of the representative subjects in Fig. 2. The lung pixels of V100% maps were categorized as normal ventilation regions (green color) and high ventilation regions (red color) by K-means cluster. It could be seen that the high ventilation regions in healthy volunteer were uniformly distributed in lungs. However, in survivors, the high ventilation regions were heterogeneous and aggregated in some regions. The high ventilation percentage (HVP) of the lungs in survivors was higher than that in healthy volunteer. Besides, the regional V(tx) curves of normal and high ventilation regions were also displayed. The slope and peak value in healthy volunteer were small. While in survivors, the regional V(tx) curves of normal ventilation regions were similar with that of healthy volunteer, but the regional V(tx) curves of high ventilation regions were obviously different with a large slope and peak value. In this way, the regional dynamic ventilation information of the subjects could be provided and quantitatively assessed.
The regional heterogeneity analysis of dynamic ventilation maps (V100% map) of the representative subjects (the same subjects in Fig. 2), and the regional V(tx) curves of these subjects. The green areas in lungs represented the normal ventilation regions, and the aggregate of all red areas in the heterogeneity maps represented the high ventilation regions. The high ventilation percentage (HVP) of the lungs was labeled in these subjects
Group analysis
Table 2 and Figure 5 display group analysis of the static FD-V map, dynamic ventilation maps (V100% map, FV100% map), dynamic ventilation parameters (HVP, V(tx) curve, FV(tx) curve, and flow-volume loop), and FVGlobal. There was no significant difference between the COVID-19 and healthy groups regarding mean value of FD-V map (0.47 ± 0.12 vs 0.42 ± 0.08; p = 0.233). However, dynamic ventilation maps and parameters all showed significant difference between survivors and healthy volunteers. The mean value of V100% map/FV100% map in survivors was significantly higher than in healthy volunteers (62.6 ± 19.3/15.1% ± 4.1% vs 37.3 ± 9.9/9.2% ± 2.1%; p < 0.001/p < 0.001). The slope of V(tx) curve/FV(tx) curve in survivors was significantly higher than in healthy volunteers (43.6 ± 17.0/8.9% ± 2.9% vs 24.3 ± 7.3/5.2% ± 1.4%; p = 0.001/p < 0.001). The area of flow-volume loop in survivors was significantly higher than in healthy volunteers (5375 ± 3978 vs 1688 ± 789; p = 0.005). Besides, the FVGlobal in survivors was also significantly higher than in healthy volunteers (12.9% ± 3.9% vs 8.8% ± 1.9%; p = 0.003).
The group analysis of FD-V map, dynamic ventilation maps (V100% map, FV100% map), dynamic ventilation parameters (HVP, V(tx) curve, FV(tx) curve, and flow-volume loop), and FVGlobal for the healthy volunteers, mild COVID-19 survivors, and severe COVID-19 survivors. The symbol * meant p < 0.05, ** meant p < 0.01, and *** meant p < 0.001
Specially, the regional heterogeneity marker (HVP) in the lungs of survivors was significantly higher than in healthy volunteers (23.7% ± 10.6% vs 13.1% ± 7.9%; p = 0.003). The HVP in 10 of 11 (90.9%) healthy volunteers were belonging to the range (5.8%, 15.9%), while only 7 of 21 (33.3%) survivors have HVP values in that range.
Validation of mPREFUL
Figure 6a shows the validation of the dynamic ventilation map (FV100% maps) by measuring the relative changes between the end-exp lung volume and end-insp lung volume of the free-breathing 1H MRI images of all subjects. The measured relative changes of lung volumes and the calculated mean FV values of FV100% maps of all subjects were 0.11 ± 0.04 and 0.13 ± 0.04, without significant difference (p = 0.142). Figure 6b shows Pearson’s correlations between the measured relative changes and the calculated mean FV values. The two methods had a good correlation (r = 0.74; p < 0.001). Figure 6c shows a Bland-Altman plot of two methods, where mean bias ± SD was −0.01 ± 0.03 (95% limit of agreement: −0.07 to 0.04). Besides, the comparisons between FV and lung volumes (e.g., functional residual capacity, tidal volume) are shown in Fig. S3 of the Supplementary Material. These results indicated the measured relative changes and the calculated mean FV values were in good agreement, and supported the accuracy of the proposed method.
The validation of dynamic ventilation maps. a The measurement of relative change between end-exp lung volume and end-insp lung volume. b The Pearson correlation between the measured relative changes of lung volumes and the calculated mean FV values of FV100% maps for all subjects. c The Bland-Altman plot of the measured relative changes of lung volumes and the calculated mean FV values of FV100% maps for all subjects
Discussion
In this study, pulmonary free-breathing 1H MRI was used to visualize and quantitatively assess regional ventilation function of COVID-19 survivors. The results showed the static FD-V map could not distinguish survivors and healthy volunteers. However, the dynamic ventilation maps revealed lots of regional high ventilation areas existed in survivors. The regional heterogeneity marker (HVP) in survivors was significantly higher than that in healthy volunteers (p = 0.003). The survivors breathed deeper, breathed more air per unit time, and breathed more air in respiratory cycle. The proposed mPREFUL was validated by FVGlobal, showing both good Pearson’s correlation and good consistency of the Bland-Altman plot.
The dynamic ventilation maps were shown to be more sensitive to detect lung function abnormity in COVID-19 survivors, compared with static ventilation maps. The concept that dynamic ventilation imaging was more sensitive to detect lung function abnormity has also been demonstrated in recent PREFUL studies [36]. In this work, the value of dynamic ventilation imaging on the assessment of regional lung function in COVID-19 survivors was demonstrated.
The mPREFUL revealed the COVID-19 survivors breathed more air in respiratory cycle. Similarly, the FVGlobal in survivors was also significantly higher than in healthy volunteers, which verified the mPREFUL findings. The global dynamic ventilation parameters could also be measured by PFTs. As reported, the tidal volume in the severe COVID-19 survivors (mean value = 1200 mL) who were discharged about 35 days was much larger than that in the healthy adults (about 500 mL) [5], which was also consistent with our findings. Nevertheless, PFTs could not provide regional information. Our study may provide some unique regional information, i.e., the regional dynamic ventilation abnormity, for the post COVID-19 researches. This regional information might be useful for interpreting the causes of lung dysfunction in COVID-19 survivors. For example, we found the increase of dynamic ventilation in COVID-19 survivors was not uniformly distributed in the lungs but was concentrated in some regions of the lungs, which could not be observed in PFTs. Furthermore, the analysis on the regional information (e.g., the correlation analysis with CT residual lesions) would lead to the regional treatment on the lungs of COVID-19 survivors.
Previous studies [35,36,37, 44] have found regional high ventilation existed in some lung diseases (e.g., cystic fibrosis) and attributed this phenomenon as compensatory hyperventilation. The PFTs [7, 9] and hyperpolarized 129Xe MRI [19] studies have shown the impairment of diffusion capacity which would reduce the efficiency of oxygen entering blood was the most common lung dysfunction in COVID-19 survivors. In this study, the high dynamic ventilation was detected in COVID-19 survivors. A reasonable explanation was the compensatory mechanism of ventilation for the survivors, i.e., the bodies of survivors possibly self-adjusted to breathe more oxygen in respiratory cycle for exchanging with blood to maintain a normal arterial partial pressure of oxygen (as detected in this work). In future, that explanation should be more rigorously evaluated by measuring the perfusion or oxygen intake in survivors.
Our study has some limitations. First, sample size was relatively small. Besides, since this study was conducted during the outbreak period of the epidemic, some subjects felt nervous and cooperated not well. Thus, 1 healthy volunteer and 6 COVID-19 survivors were excluded because of image quality (e.g., motion artifacts). Second, only one coronal slice was acquired although this was a usual setting in free-breathing 1H MRI [23]. However, the acquisition with more slices could image whole lung, which is needed in future. Third, detailed regional structural information was insufficient due to current limitation of free-breathing 1H MRI. In the future, multiple modality imaging methods (such as CT, hyperpolarized 129Xe MRI, and free-breathing 1H MRI) should be developed to assess regional lung function of COVID-19 survivors.
In summary, the pulmonary free-breathing 1H MRI was used to visualize and quantitatively assess regional lung ventilation function of COVID-19 survivors. The dynamic ventilation maps and parameters were more sensitive to distinguish the survivors and healthy volunteers, compared with static ventilation map. The dynamic ventilation imaging found the regional lung function abnormity in COVID-19 survivors. Pulmonary free-breathing 1H MRI would be an optional method in clinical to examine regional lung function for the huge number of COVID-19 survivors to understand the long-COVID symptoms and identify the impairment where clinical features cannot.
Abbreviations
- End-exp:
-
End-expiration
- End-insp:
-
End-inspiration
- FD:
-
Fourier decomposition
- FD-V:
-
FD ventilation
- FRC:
-
Full respiratory cycle
- FV:
-
Fractional ventilation
- FVGlobal :
-
Global fractional ventilation
- HVP:
-
High ventilation percentage
- PREFUL:
-
Phase-resolved functional lung
References
Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med 382(8):727–733
World Health Organization (2021) Coronavirus disease (COVID-2019) situation reports. Available via https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19-30-november-2021. Accessed 2 Dec 2021
Mo X, Jian W, Su Z et al (2020) Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 55:2001217
Hui DS, Joynt GM, Wong KT et al (2005) Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 60:401–409
You J, Zhang L, Ni-Jia-Ti MY et al (2020) Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J Infection 81(2):e150–e152
Li X, Wang C, Kou S, Luo P, Zhao M, Yu K (2020) Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study. Crit Care 24(1):300
Huang Y, Tan C, Wu J et al (2020) Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Resp Res 21(1):163
Arnold DT, Hamilton FW, Milne A et al (2021) Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 76(4):399–401
Guler SA, Ebner L, Beigelman C et al (2021) Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J 57(4):2003690
Pellegrino R, Viegi G, Brusasco, et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948-968
King GG, Harris B, Mahadev S (2010) V/Q SPECT: utility for investigation of pulmonary physiology. Semin Nucl Med 40(6):467–473
Cobes N, Guernou M, Lussato D et al (2020) Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series. Eur J Nucl Med Mol I 47:10223
Kipritidis J, Tahir BA, Cazoulat G et al (2019) The VAMPIRE challenge: a multi-institutional validation study of CT ventilation imaging. Med Phys 46(3):1198–1217
Shao W, Patton TJ, Gerard SE et al (2019) N-phase local expansion ratio for characterizing out-of-phase lung ventilation. IEEE T Med Imaging 39(6):2025–2034
Wang C, Huang L, Xiao S et al (2021) Early prediction of lung lesion progression in COVID-19 patients with extended CT ventilation imaging. Eur J Nucl Med Mol I 48:4339–4349
Zhou X, Graziani D, Pines A (2009) Hyperpolarized xenon NMR and MRI signal amplification by gas extraction. Proc Natl Acad Sci U S A 106(40):16903–16906
Kauczor HU, Surkau R, Roberts T (1998) MRI using hyperpolarized noble gases. Eur Radiol 8(5):820–827
Li H, Zhang Z, Zhao X et al (2016) Quantitative evaluation of radiation-induced lung injury with hyperpolarized xenon magnetic resonance. Magn Reson Med 76(2):408–416
Li H, Zhao X, Wang Y, et al (2021) Damaged lung gas-exchange function of discharged COVID-19 patients detected by hyperpolarized 129Xe MRI. Sci Adv 7(1):eabc8180
Puderbach M, Eichinger M, Gahr J et al (2007) Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 17(3):716–724
Voskrebenzev A, Vogel-Claussen J (2021) Proton MRI of the lung: how to tame scarce protons and fast signal decay. J Magn Reson Imaging 53:1344–1357
Zapke M, Topf H, Zenker M et al (2006) Magnetic resonance lung function – a breakthrough for lung imaging and functional assessment? A phantom study and clinical trial. Resp Res 7(1):106
Bauman G, Puderbach M, Deimling M et al (2009) Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of Fourier decomposition in proton MRI. Magn Reson Med 62(3):656–664
Bauman G, Lutzen U, Ullrich M et al (2011) Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR Imaging with SPECT/CT in porcine lung. Radiology 260(2):551–559
Bauman G, Scholz A, Rivoire J et al (2013) Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: in vivo validation with hyperpolarized 3He and dynamic contrast-enhanced MRI. Magn Reson Med 69(1):229–237
Pennati F, Quirk JD, Yablonskiy DA, Castro M, Aliverti A, Woods JC (2014) Assessment of regional lung function with multivolume 1H MR imaging in health and obstructive lung disease: comparison with 3He MR imaging. Radiology 273(2):580–590
Pennati F, Salito C, Borzani I et al (2019) Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators. Eur Respir J 53(5):1702020
Capaldi DP, Eddy RL, Svenningsen S et al (2018) Free-breathing pulmonary MR imaging to quantify regional ventilation. Radiology 287(2):171993
Capaldi DP, Guo F, Xing L, Parraga G (2020) Pulmonary ventilation maps generated with free-breathing proton MRI and a deep convolutional neural network. Radiology 298(2):202861
Guo F, Capaldi DP, Mccormack DG, Fenster A, Parraga G (2019) A framework for Fourier-decomposition free-breathing pulmonary 1H MRI ventilation measurements. Magn Reson Med 81(3):2135–2146
Chassagnon G, Martin C, Marini R et al (2019) Use of elastic registration in pulmonary MRI for the assessment of pulmonary fibrosis in patients with systemic sclerosis. Radiology 291(2):487–492
Heidenreich JF, Weng AM, Metz C et al (2020) Three-dimensional ultrashort echo time MRI for functional lung imaging in cystic fibrosis. Radiology 296(1):191–199
Marshall H, Deppe MH, Parra-Robles J et al (2011) Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax 67(7):613–617
Xiao S, Deng H, Duan C et al (2019) Highly and adaptively undersampling pattern for pulmonary hyperpolarized 129Xe dynamic MRI. IEEE T Med Imaging 38(5):1240–1250
Voskrebenzev A, Gutberlet M, Klimes F et al (2018) Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med 79(4):2306–2314
Alsady TM, Voskrebenzev A, Greer M et al (2019) MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction. J Magn Reson Imaging 50(6):1873–1882
Kaireit TF, Kern A, Voskrebenzev A et al (2021) Flow volume loop and regional ventilation assessment using phase-resolved functional lung (PREFUL) MRI: comparison with 129Xenon ventilation MRI and lung function testing. J Magn Reson Imaging 53(4):1092–1105
Pöhler GH, Klimeš F, Behrendt L et al (2021) Repeatability of phase-resolved functional lung (PREFUL)-MRI ventilation and perfusion parameters in healthy subjects and COPD patients. J Magn Reson Imaging 53:915–927
Klimeš F, Voskrebenzev A, Gutberlet M et al (2021) 3D phase-resolved functional lung ventilation MR imaging in healthy volunteers and patients with chronic pulmonary disease. Magn Reson Med 85(2):912–925
Voskrebenzev A, Gutberlet M, Becker L, Wacker F, Vogel-Claussen J (2016) Reproducibility of fractional ventilation derived by Fourier decomposition after adjusting for tidal volume with and without an MRI compatible spirometer. Magn Reson Med 76(5):1542–1550
National Health Commission of the People’s Republic of China (2020) Guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV) infection (trial version 7). Available via https://www.who.int/docs/default-source/wpro%2D%2D-documents/countries/china/covid-19-briefing-nhc/1-clinical-protocols-for-the-diagnosis-and-treatment-of-covid-19-v7.pdf?sfvrsn=c6cbfba4_2. Accessed 2 Dec 2021
Brookes GB, Fairfax AJ (1982) Chronic upper airway obstruction: value of the flow volume loop examination in assessment and management. J R Soc Med 75:425–434
Kirby M, Heydarian M, Svenningsen S et al (2012) Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 19(2):141–152
Gouwens KR, Higano NS, Marks KT et al (2020) Magentic resonance imaging evaluation of regional lung Vts in severe neonatal bronchopulmonary dysplasia. Am J Resp Cirt Care Med 202(7):1024–1031
Acknowledgements
Specially thanks to Dr. Sa Xiao for his help in this work.
Funding
This work was supported by the National key Research and Development Project of China (2018YFA0704000), National Natural Science Foundation of China (91859206, 81625011, 21921004, 81825012, 82001915), Key Research Program of Frontier Sciences (ZDBS-LY-JSC004), and China Postdoctoral Science Foundation (2020M672454, 2020T130125ZX). Xin Zhou acknowledges the support from the Tencent Foundation through the XPLORER PRIZE.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Xin Zhou.
Conflict of Interest
The authors declare no competing interests.
Statistics and Biometry
No complex statistical methods were necessary for this paper.
Informed Consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical Approval
Institutional Review Board approval was obtained.
Methodology
• prospective
• diagnostic or prognostic study
• performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOC 5111 kb)
Rights and permissions
About this article
Cite this article
Wang, C., Li, H., Xiao, S. et al. Abnormal dynamic ventilation function of COVID-19 survivors detected by pulmonary free-breathing proton MRI. Eur Radiol 32, 5297–5307 (2022). https://doi.org/10.1007/s00330-022-08605-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-022-08605-w